IP Library Granted Patent US 10,823,719
Granted Patent B2
US 10,823,719 · App. 15/753,303 · Granted Nov 3, 2020

Rapid test for bacteria

Inventors: Dieter Ebert (Gottlieben, CH); Mathias Reichl (Kehlheim, DE); Werner Lubitz (Kritzendorf, AT)
Assignee: Swiss Analyze Bacteria AG
G01N33/1826G01N33/537G01N33/56911G01N33/582G01N21/03G01N21/65G01N2333/195
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,823,719
App. No.
15/753,303
Granted
Nov 3, 2020
Kind
B2
Abstract

The invention relates to methods and devices for quantitative determination of bacteria.

Claims (15)

1. A method for quantitatively determining bacteria in a sample, comprising the steps of:

(a) incubating the sample to be tested together with a labelling reagent that can bind to the bacteria to be determined in a measuring cell with a first and a second chamber, wherein the labelling reagent is a labelled bacteriophage, preferably a fluorescence-labelled bacteriophage, a luminescence-labelled bacteriophage or a Raman-labelled bacteriophage, and is used in excess with respect to the bacteria to be detected, wherein said sample is incubated in the first chamber of said measuring cell,

(b) removing labelling reagent that has not bound to the bacteria from the bacteria by means of a membrane between said first and second chamber, wherein said membrane is impermeable to the bacteria to be determined and is permeable to the labelling reagent, wherein the bacteria to be determined are collected on the membrane and said labelling reagent that has not bound to the bacteria is moved into said second chamber,

(c) detecting the labelling reagent bound to the bacteria collected on said membrane, preferably by means of fluorescence measurement, luminescence measurement and/or Raman measurement, and

(d) quantitatively evaluating the measurement signal from step (c).

2. The method according to claim 1 , wherein the bacteria are selected from the group consisting of legionella, salmonella, listeria , coliform germs including E. coli , and hospital germs including MRSA.

3. The method according to claim 1 , wherein

the first chamber contains a store for the labelling reagent.

4. The method according to claim 1 , wherein said membrane has a pore diameter of approximately 0.5 to 3 μm.

5. The method according to claim 1 , wherein the labelling reagent and the sample to be tested are mixed before and/or during the incubation procedure in step (a).

6. The method according to claim 1 , wherein the labelling reagent bound to the bacteria is detected in step (c) using a laser with a confocal optic as the light source.

7. The method according to claim 6 , wherein the laser is used in an integrated device together with a spectrometer so as to form a detection unit.

8. The method according to claim 1 , wherein the quantitative evaluation in step (d) comprises sorting a specific number of bacteria into one or more categories on the basis of predetermined threshold values.

9. The method according to claim 1 , wherein at least one reference signal, in particular a reference signal generated by a laser, is used for the quantitative evaluation in step (d).

10. The method according to claim 2 , wherein the coliform germ is Escherichia coli , and the hospital germ is Methicillin-resistant Staphylococcus aureus.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 20, 2018
From: EBERT, DIETER; REICHL, MATHIAS; LUBITZ, WERNER
To: SWISS ANALYZE BACTERIA AG
Reel/Frame 045599/0726 →
Priority Claims (1)
EP 15181240 · Aug 17, 2015 · regional
Continuity (1)
Related Publication 20180238849A1 · Aug 23, 2018